Ignite Creation Date:
2025-12-24 @ 1:32 PM
Ignite Modification Date:
2026-03-28 @ 6:47 AM
Study NCT ID:
NCT06098495
Status:
RECRUITING
Last Update Posted:
2023-10-24
First Post:
2023-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Looking for a Blood Epigenetic Signature to Predict Female Infertility
Sponsor:
Università Vita-Salute San Raffaele
Organization:
Study Overview
Official Title:
Looking for a Blood Epigenetic Signature to Predict Female Infertility
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FIB_CARIPLO
Brief Summary:
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: